Article Text

Download PDFPDF
CASE REPORT
Rare presentation of granulomatosis with polyangiitis
  1. Adam Hines1,
  2. Vered Bello1,
  3. Asma Iftikhar2 and
  4. Hadi Zein1
  1. 1 Department of Internal Medicine, New York-Presbyterian/Queens, Flushing, New York, USA
  2. 2 Department of Pulmonary and Critical Care, New York-Presbyterian/Queens, Flushing, New York, USA
  1. Correspondence to Dr Asma Iftikhar, doctorasmi{at}gmail.com

Abstract

A 62-year-old man with no pertinent medical history presented with lower extremity weakness and worsening distal fingertips and toe cyanosis/gangrene. In the outpatient setting, he was initially being treated for Raynaud’s phenomenon with a calcium channel blocker. On presentation, the patient had elevated inflammatory markers and white blood cell count. Serum vasculitis panel (proteinase-3 antibody) supported the diagnosis of granulomatosis with polyangiitis. His hospital course was complicated by ischaemic stroke and a diagnosis of mononeuritis multiplex in his lower extremities. After initiating therapy with intravenous steroid and rituximab, his symptoms overall improved including cyanotic fingertips/toes. His inflammatory markers and leucocytosis also improved. Outpatient follow-up consisted of further rituximab infusions and unrelated umbilical hernia incarceration which required surgery. He was found incidentally to have subsegmental pulmonary emboli which most likely occurred during the initial presentation prior to his diagnosis. The patient moved out of state and was lost to follow-up.

  • vasculitis
  • rheumatology

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors AH and VB: data analysis and interpretation; drafting the manuscript. AH: revision of the manuscript and final approval; accepts responsibility for conduct of research. HZ: drafting of the manuscript and accepts responsibility for the conduct of research. AI: study concept and design, study supervision, revising the manuscript, final approval and accepts responsibility for conduct of research.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.